These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30778250)

  • 1. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
    Hollande C; Boussier J; Ziai J; Nozawa T; Bondet V; Phung W; Lu B; Duffy D; Paradis V; Mallet V; Eberl G; Sandoval W; Schartner JM; Pol S; Barreira da Silva R; Albert ML
    Nat Immunol; 2019 Mar; 20(3):257-264. PubMed ID: 30778250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.
    Barreira da Silva R; Laird ME; Yatim N; Fiette L; Ingersoll MA; Albert ML
    Nat Immunol; 2015 Aug; 16(8):850-8. PubMed ID: 26075911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.
    Forssmann U; Stoetzer C; Stephan M; Kruschinski C; Skripuletz T; Schade J; Schmiedl A; Pabst R; Wagner L; Hoffmann T; Kehlen A; Escher SE; Forssmann WG; Elsner J; von Hörsten S
    J Immunol; 2008 Jul; 181(2):1120-7. PubMed ID: 18606664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
    Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
    IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
    Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
    Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
    Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.
    Decalf J; Tarbell KV; Casrouge A; Price JD; Linder G; Mottez E; Sultanik P; Mallet V; Pol S; Duffy D; Albert ML
    EMBO Mol Med; 2016 Jun; 8(6):679-83. PubMed ID: 27137491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
    Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
    J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway.
    He Q; Cao H; Zhao Y; Chen P; Wang N; Li W; Cui R; Hou P; Zhang X; Ji M
    Thyroid; 2022 Nov; 32(11):1411-1422. PubMed ID: 36166219
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
    Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
    Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
    Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma.
    Kamada S; Namekawa T; Ikeda K; Suzuki T; Kagawa M; Takeshita H; Yano A; Okamoto K; Ichikawa T; Horie-Inoue K; Kawakami S; Inoue S
    Oncogene; 2021 Jun; 40(22):3899-3913. PubMed ID: 33972682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a
    Yazbeck R; Jaenisch S; Squire M; Abbott CA; Parkinson-Lawrence E; Brooks DA; Butler RN
    Sci Rep; 2019 Mar; 9(1):4906. PubMed ID: 30894647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
    Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
    Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.